Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |